|Chemical and physical data|
|3D model (Jmol)||Interactive image|
Benzhydrocodone (INN) (contracted from benzoate-hydrocodone) is a opioid prodrug of the morphinan class. Its chemical structure consists of hydrocodone coupled with benzoic acid. Benzhydrocodone itself is inactive and acts as a prodrug to hydrocodone upon cleavage of the benzoate portion of the molecule.
Created by a biopharmaceutical company in Coralville, Iowa. President and CEO, Travis Mickle, believes the molecular-based approach to abuse-detterent may be more effective than many formulation-based approaches.
- KemPharm, Inc. (June 11, 2013). "KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201" (Press release). North Liberty, Iowa: PR Newswire. Retrieved February 8, 2015.
- Lavitt, John (June 12, 2014). "New Abuse-Resistant Opioid Receives $60 Million Backing". http://thefix.com/. The Fix. Retrieved February 8, 2015. External link in
- "KP201/APAP". http://www.kempharm.com/. Retrieved April 20, 2015. External link in